Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of GAS2L3 mRNA | increases expression | 20713471
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of GAS2L3 mRNA | decreases expression | 20064835
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of GAS2L3 mRNA | increases expression | 20713471
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GAS2L3 mRNA | decreases expression | 19150397 20382639 20018196
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of GAS2L3 mRNA | decreases expression | 20106945
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene results in decreased expression of GAS2L3 mRNA | decreases expression | 20713471
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of GAS2L3 mRNA | increases expression | 20713471
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GAS2L3 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of GAS2L3 mRNA | increases expression | 18301758
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of GAS2L3 mRNA | decreases expression | 17998272
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GAS2L3 mRNA | increases expression | 20159946
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of GAS2L3 mRNA | increases expression | 17127020
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.08 | 11752688 14514962 15322242 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.30 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.02 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
11.90 | 10737359 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
11.90 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
11.90 | 6695378 10545420 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
6.27 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.71 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.71 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.96 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.17 | 17306315 16712894 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.29 | 19183758 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.55 | 11922910 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.35 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.35 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
2.02 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.02 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.02 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.02 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
8.80 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.80 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
3.47 | 3084413 10737359 6705139 3581430 17761372 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.47 | 15276417 17306315 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.74 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.74 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 18670907 16120746 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
17.02 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
17.02 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
17.02 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
17.02 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.18 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.18 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.49 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.57 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.11 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.11 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.48 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.48 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.14 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.14 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
5.18 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.21 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.21 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.92 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.72 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.72 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.63 | 20558911 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
5.58 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
4.58 | 6705139 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.99 | 16221962 19772884 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.99 | 12621046 16120746 15340226 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.30 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 18606429 8697196 16354765 15340226 16959395 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.34 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.14 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.14 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.10 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.93 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.74 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.32 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.32 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.88 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.18 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.18 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
14.88 | 11376686 18001218 14678523 10737359 10672840 16273603 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.88 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.88 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
14.88 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.88 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
10.61 | 6150874 1399818 534488 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
10.61 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.61 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.28 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
6.80 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.80 | 18816296 18520028 20464547 20064080 17053015 20869020 18569708 6695378 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
6.80 | 16271038 20512841 16337739 6695378 1399818 21163286 20970405 17909032 15390079 11893704 9230183 10545420 7750092 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.80 | 19931552 17306315 15276417 16712894 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.80 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
3.68 | 11921183 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.05 | 16487513 19082730 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.32 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.72 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.20 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.08 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.66 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.66 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.66 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.88 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.25 | 12854658 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.48 | 15276417 17306315 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.37 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.43 | 11118676 11896295 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.15 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.15 | 16039940 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.46 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.83 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.83 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.83 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.93 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
8.78 | 15289314 1399818 15867355 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.78 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.78 | 16712894 16452187 17306315 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.93 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.66 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |